NVO Q2 2016 Earnings Report — Novo Nordisk A/S Revenue & Financial Results | Market Cap Arena

Novo Nordisk A/SNVO

Q2 2016 Earnings

Reported June 29, 2016

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	Q2 2016	Q1 2016	Q2 2015	QoQ Change	YoY Change
Revenue	$4.3B	$4.3B	—	0.9%	—
Op. Income	$2.0B	$1.9B	—	1.5%	—
Gross Margin	85.3%	84.4%	—	0.8pp	—
Net Margin	36.3%	34.7%	—	1.6pp	—
EPS (Diluted)	$0.31	$0.29	—	5.4%	—
Free Cash Flow	$2.0B	$994M	—	101.2%	—

Revenue Flow

Item	Amount
REVENUE	$4.3B
Cost of Revenue	$635M
GROSS PROFIT	$3.7B
R&D Expenses	$523M
Selling & Marketing	$1.1B
General & Administrative	$137M
SG&A Expenses	$1.2B
Other Expenses	-$24M
Operating Expenses	$1.7B
Cost & Expenses	$2.3B
OPERATING INCOME	$2.0B
Interest Income	$16M
Interest Expense	$2M
Other Income/Expenses	$16M
INCOME BEFORE TAX	$2.0B
Income Tax Expense	$413M
Net Income from Continuing Ops	$1.6B
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$1.6B
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$1.6B
D&A	$113M
EBIT	$2.0B
EBITDA	$2.1B
EPS	$0
EPS Diluted	$0

Income Statement

Item	Amount
REVENUE	$4.3B
Cost of Revenue	$635M
GROSS PROFIT	$3.7B
R&D Expenses	$523M
Selling & Marketing	$1.1B
General & Administrative	$137M
SG&A Expenses	$1.2B
Other Expenses	-$24M
Operating Expenses	$1.7B
Cost & Expenses	$2.3B
OPERATING INCOME	$2.0B
Interest Income	$16M
Interest Expense	$2M
Other Income/Expenses	$16M
INCOME BEFORE TAX	$2.0B
Income Tax Expense	$413M
Net Income from Continuing Ops	$1.6B
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$1.6B
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$1.6B
D&A	$113M
EBIT	$2.0B
EBITDA	$2.1B
EPS	$0
EPS Diluted	$0

Cash Flow Statement

Item	Amount
Net Income	$1.6B
Depreciation & Amortization	$113M
Stock-Based Compensation	$0
Deferred Income Tax	$413M
Other Non-Cash Items	$33M
Change in Working Capital	$381M
OPERATING CASH FLOW	$2.3B
Capital Expenditure	-$276M
Acquisitions (Net)	$11M
Purchases of Investments	-$6M
Sales/Maturities of Investments	$317M
Other Investing Activities	-$11M
NET CASH FROM INVESTING	$35M
Net Debt Issuance	$0
Common Stock Repurchased	-$566M
Common Dividends Paid	$0
Other Financing Activities	-$441M
NET CASH FROM FINANCING	-$1.0B
FREE CASH FLOW	$2.0B
Net Change in Cash	$1.3B

Balance Sheet

Item	Amount
Cash & Equivalents	$2.1B
Short-Term Investments	$322M
Net Receivables	$2.5B
Inventory	$2.1B
Other Current Assets	$1.3B
TOTAL CURRENT ASSETS	$8.3B
PP&E (Net)	$4.3B
Goodwill	$0
Intangible Assets	$331M
Long-Term Investments	$306M
Tax Assets	$700M
Other Non-Current Assets	$0
TOTAL NON-CURRENT ASSETS	$5.6B
TOTAL ASSETS	$13.9B
Account Payables	$837M
Short-Term Debt	$64M
Deferred Revenue	$3.4B
Other Current Liabilities	$2.2B
TOTAL CURRENT LIABILITIES	$6.5B
Long-Term Debt	$0
Deferred Revenue NC	$0
Deferred Tax Liabilities	$2M
Other Non-Current Liabilities	$652M
TOTAL NON-CURRENT LIABILITIES	$652M
TOTAL LIABILITIES	$7.2B
Common Stock	$80M
Additional Paid-In Capital	$80M
Retained Earnings	$6.7B
Treasury Stock	-$627.6K
Accum. Other Comp. Income	-$68M
Other Equity	-$80M
TOTAL STOCKHOLDERS' EQUITY	$6.7B
Minority Interest	$0
TOTAL EQUITY	$6.7B
TOTAL LIABILITIES & EQUITY	$13.9B
Total Debt	$64M
Net Debt	-$2.0B